fms样酪氨酸激酶4,fms like tyrosine kinase 4
1)fms like tyrosine kinase 4fms样酪氨酸激酶4
1.Objective To investigate the expression of Tiam-1(T lymphoma invasion and metastasis)and Flt-4(fms like tyrosine kinase 4)proteins in thyroid papillary carcinomas and their roles in the development of thyroid carcinoma.目的探讨T淋巴瘤侵袭转移基因(Tiam-1)和fms样酪氨酸激酶4(Flt-4)在甲状腺乳头状癌和正常甲状腺以及腺瘤组织中的表达情况,研究其在甲状腺乳头状癌发生和发展中的作用。
2)Flt-1fms样酪氨酸激酶
1.The Sensitivity ofFlt-1 Gene of Men of Han Nationality in Northern China to the HiHiLo Training;中国北方汉族男子fms样酪氨酸激酶基因多态性与高住高练低训敏感性的关联性研究
英文短句/例句
1.The name is soluble f-m-s-like tyrosine kinase one?这种蛋白质叫做可溶解fms样酪氨酸激酶一，
2.The Primary Study of the Relationship between Tyrosine Protein Kinase and Salivary Adenoid Cystic Carcinoma酪氨酸蛋白激酶与涎腺腺样囊性癌的关系的初步研究
3.Effects of beta-amyloid protein on expression of tyrosine kinase receptor A in neural stem cellsβ淀粉样蛋白对神经干细胞酪氨酸蛋白激酶A表达的影响
4.Preliminary Research of RAI16 Protein Interacting with Tec Tyrosine Kinase;Tec酪氨酸激酶作用蛋白RAI16的初步研究
5.Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
6.The Research of Antibody Against Muscle-specific Tyrosine Kinase in Myasthenia Gravis among Chinese;重症肌无力患者酪氨酸激酶抗体的相关研究
7.Tec Tyrosine Protein Kinase Involved in Multidrug Resistance of Hepatocelluar Carcinoma;Tec酪氨酸蛋白激酶参与肝癌多药耐药的研究
8.c-Abl Stabilizes Estrogen Receptor by Phosphorylation and Regulates Its Transcription Activity;c-Abl非受体酪氨酸激酶调节ERα转录活性的研究
9.Study on the Prevalence of Protein Tyrosine Kinase JAK2V617F Mutation in the Western Population;西方人群中蛋白质酪氨酸激酶JAK2~（V617F）突变率研究
10.Expression and Clinical Significance of Receptor Tyrosine Kinase RON in Lung Carcinoma肺癌组织中酪氨酸激酶受体RON的表达及意义
11.Molecular targeted therapies:targeting receptor tyrosine kinases in the treatment of gastric cancer靶向于受体酪氨酸激酶的胃癌分子靶向治疗
12.Tyrosine Kinase Mutation and Acute Myeloid Leukemia with t(8;21)酪氨酸激酶突变与t(8;2急性髓系白血病
13.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
14.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
15.Advances in the research of multi-target tyrosine kinase inhibitors多靶点抗肿瘤酪氨酸激酶抑制剂的研究开发
16.Expression of receptor tyrosine kinase EphA7 in gastric carcinoma and its clinical significances受体酪氨酸激酶EphA7基因在胃癌中的表达及意义
17.Effect of Receptor Protein-tyrosine Kinases in Tumor Angiogenesis受体酪氨酸激酶在肿瘤血管新生中的作用
18.Progress in research of multi-targeted inhibitors of receptor tyrosine kinase多靶点受体酪氨酸激酶抑制剂的研究进展
相关短句/例句
Flt-1fms样酪氨酸激酶
1.The Sensitivity ofFlt-1 Gene of Men of Han Nationality in Northern China to the HiHiLo Training;中国北方汉族男子fms样酪氨酸激酶基因多态性与高住高练低训敏感性的关联性研究
3)c-fms-like tyrosine (kinase)-4c-fms样酪氨酸蛋白激酶4
4)Fms-like tyrosine kinase-1fms样酪氨酸激酶-1
5)FMS-like tyrosine kinase 3 ligandFMS样酪氨酸激酶3配体
1.Aim:To clone the cDNA ofFMS-like tyrosine kinase 3 ligand(Flt3L) and to construct the prokaryotic expression vector for the Flt3 ligand extracellular domain fused with a His6 tag and express in Escherichia coli(E.目的:构建含组氨酸标签的FMS样酪氨酸激酶3配体(Fms-like tyrosine kinase 3 ligand,Flt3L)胞外域蛋白的原核表达载体,并在大肠杆菌中进行表达。
6)FMS-like tyrosine kinase-3 (FLT-3)FMS样酪氨酸激酶3(FLT-3)
延伸阅读
[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]分子式：C16H16ClN3O3S分子量：365.5CAS号：26807-65-8性质：暂无制备方法：暂无用途：用于轻、中度原发性高血压。
